Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.37
-0.03 (-0.56%)
At close: Apr 29, 2026
19.33%
Market Cap 1.32B
Revenue (ttm) 106.02M
Net Income (ttm) -42.47M
Shares Out 244.71M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 39,800
Average Volume 56,580
Open 5.62
Previous Close 5.40
Day's Range 5.37 - 5.64
52-Week Range 4.03 - 8.00
Beta -0.94
RSI 40.53
Earnings Date Mar 27, 2026

About HKG:6922

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People’s Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2013
Employees 174
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6922
Full Company Profile

Financial Performance

In 2025, HKG:6922's revenue was 95.27 million, an increase of 77.97% compared to the previous year's 53.53 million. Losses were -38.17 million, -63.43% less than in 2024.

Financial numbers in CNY Financial Statements

News

There is no news available yet.